Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
In their recent article (Rethinking sexual pleasure in research, health care and society. Nat. Rev. Urol. 23, 333–349; 2026), Dewitte and Borg offer an important contribution to contemporary sexual medicine by arguing for a more profound integration of sexual pleasure into research, clinical practice and public discourse1.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Introduction Duchenne muscular dystrophy (DMD) is characterized by progressive muscle damage resulting from a mutation in the dystrophin gene that disrupts dystrophin function.1 Chronic corticosteroid treatment is the primary pharmaceutical option.2, 3 Prednisone and deflazacort are the two corticosteroids used to treat DMD.4 Corticosteroid treatment is considered the standard of care; however, both daily and intermittent dosing regimens exist and are generally chosen based on perceived...
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
